Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the National Cancer Advisory Board.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4), and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Advisory Board Ad hoc Subcommittee on Experimental Therapeutics.                    

*Open:*                         June 21, 2010, 6:30 p.m. to 8 p.m.                    

*Agenda:*                         Discussion on Experimental Therapeutics.                    

*Place:*                         Embassy Suites, Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015.                    

*Contact Person:*                         Dr. Joseph Tomaszewski, Executive Secretary, NCAB Ad hoc Subcommittee on Experimental Therapeutics, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD 20892–8345, (301) 496–8531.                    

*Name of Committee:*                         National Cancer Advisory Board.                    

*Open:*                         June 22, 2010, 8 a.m. to 4 p.m.                    

*Agenda:*                         Program reports and presentations; business of the Board.                    

*Place:*                         National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.                    

*Contact Person:*                         Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892–8327, (301) 496–5147.                    

*Name of Committee:*                         National Cancer Advisory Board.                    

*Closed:*                         June 22, 2010, 4 p.m. to adjournment.                    

*Agenda:*                         Review of grant applications.                    

*Place:*                         National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.                    

*Contact Person:*                         Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892–8327, (301) 496–5147.                    

*Name of Committee:*                         National Cancer Advisory Board.                    

*Open:*                         June 23, 2010, 8:30 a.m. to 12 p.m.                    

*Agenda:*                         Program reports and presentations; business of the Board.                    

*Place:*                         National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.                    

*Contact Person:*                         Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892–8327, (301) 496–5147.                    

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

                        In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on                               ( print page 26268)                            campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.                    

                        Information is also available on the Institute's/Center's home page:                         *http://deainfo.nci.nih.gov/​advisory/​ncab.htm,*                         where an agenda and any additional information for the meeting will be posted when available.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: May 3, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010–11070 Filed 5–10–10; 8:45 am]

BILLING CODE 4140–01–P